GLENMARK / NSE / Biotechnology & Drugs
Glenmark Pharmaceuticals
1Y Price Trend
Key Information
Recommendations
RatingStrong Buy
Target High2,471.05
Target Low1,793.5
Target Mean1.78
Target Median97.22
Risk Metrics
Overall RiskBalanced risk
Board Risk31.48
Key Analysis
Overall score, performance score, return rating, defensive, aggressive, and balanced views.
Download appProjection Analytics
Best-case, base-case, worst-case, and dynamic AI projection views.
Download appLatest stock news
Glenmark Consolidated March 2026 Net Sales at Rs 3,770.59 crore, up 15.8% Y-o-Y Moneycontrol.com
Number of shareholders of Glenmark Pharmaceuticals Limited – NSE:GLENMARK TradingView
Glenmark Pharmaceuticals Ltd. is Rated Strong Buy Markets Mojo
Glenmark Pharmaceuticals Q4 FY26: Exceptional Quarter Marred by Sequential Decline Markets Mojo
Glenmark Pharmaceuticals appoints Ajay Jajoo as Group VP & Global Corporate Controller Exchange4Media
Glenmark Pharma targets ₹18,000 crore revenue by FY27 on broad-based global growth CNBC TV18
Buy Glenmark Pharma; target of Rs 2610: Motilal Oswal Moneycontrol.com
Glenmark Pharmaceuticals Ltd. Technical Momentum Shifts Amid Mixed Indicator Signals Markets Mojo
Stock FAQs
What is the symbol and ISIN of Glenmark Pharmaceuticals?
Glenmark Pharmaceuticals has the symbol GLENMARK and ISIN - INE935A01035.
What is the current price of Glenmark Pharmaceuticals?
Glenmark Pharmaceuticals is currently trading at INR 2,289.20.
What are the year high and year low of Glenmark Pharmaceuticals?
Glenmark Pharmaceuticals has a year high of INR 2,471.05 and a year low of INR 1,793.50.
What is the market capitalization of Glenmark Pharmaceuticals?
Glenmark Pharmaceuticals has a market capitalization of INR 64,049.80 crore.
What is the P/E ratio of Glenmark Pharmaceuticals?
Glenmark Pharmaceuticals has a P/E ratio of 44.17.
What is the dividend yield of Glenmark Pharmaceuticals?
Glenmark Pharmaceuticals has a dividend yield of 0.22%.
How is the financial performance of Glenmark Pharmaceuticals based on revenue, net income, and EPS?
Glenmark Pharmaceuticals has revenue of INR 1,69,825.10 crore, net income of INR 13,618.51 crore, and EPS of INR 100.04.
What is the book value of Glenmark Pharmaceuticals?
Glenmark Pharmaceuticals has a book value of INR 283.70.
What is the debt-to-equity ratio of Glenmark Pharmaceuticals?
Glenmark Pharmaceuticals has a debt-to-equity ratio of NA.
What are the price-to-book and price-to-sales ratios of Glenmark Pharmaceuticals?
Glenmark Pharmaceuticals has a price-to-book ratio of 8.07 and a price-to-sales ratio of 0.38.
© SharekeyX | Rusaka Technologies 2024-2026